journal article·2026-03Open access

Photothermal–Immunomodulatory Hydrogel Reinforced by Ti 3 C 2 /ZnAl‐LDH Nanoplatform for Eradicating MRSA and Promoting Diabetic Wound Healing

Qiang Shi, Renliang Zhao, Jia Wang, Zhenchen Xiong, Xiangtian Deng, Cheng Zheng, Wenzhi Zhang

Advanced Science· Volume 13· Issue 17

Abstract

ABSTRACT MRSA infections give rise to chronic cutaneous and advance into profound tissue invasions, including osteomyelitis and sepsis—conditions for which existing clinical interventions offer only limited efficacy. The utility of broad‐spectrum antibiotics has become increasingly compromised by escalating drug resistance, inadequate tissue targeting, and deleterious side effects. Neutrophil extracellular traps (NETs) have emerged as a compelling immunotherapeutic avenue for eradicating multidrug‐resistant pathogens. Inspired by the bactericidal and immunoregulatory functions of NETs, we developed a photothermal–immunomodulatory hydrogel reinforced by a Ti 3 C 2 /ZnAl‐LDH nanoplatform to mimic NETs‐like antimicrobial defense while overcoming their inherent limitations. Hollow photothermal nanoparticles were fabricated from 2D Ti 3 C 2 and ZnAl‐LDH (TiZ) nanosheets and infused with chlorogenic acid, forming CTiZ. These were cloaked in membranes derived from apoptotic neutrophils to create a NETs‐mimetic functional bacterial trapper (CTiZM), which was then encapsulated within a thermoresponsive dopa‐poly(N‐isopropylacrylamide) hydrogel (dopa‐PNIPAm, DP), yielding a composite hydrogel system designated CTiZM@DP. This sophisticated platform amplifies antibacterial potency through effective microbial entrapment and the generation of reactive oxygen species, while simultaneously orchestrating the polarization of macrophages toward a reparative M2 phenotype under the influence of gentle photothermal stimulation. Collectively, this integrative strategy heralds a promising therapeutic modality for the eradication of multidrug‐resistant infections and the enhancement of wound healing in individuals with diabetes.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Neutrophil, Myeloperoxidase and Oxidative Mechanisms · Wound Healing and Treatments

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of orthopaedics The First Affiliated Hospital of USTC Division of Life Sciences and Medicine University of Science and Technology of China Hefei Anhui P. R. China

Orthopedics Research Institute Department of Orthopedics West China Hospital Sichuan University Chengdu P. R. China

Trauma Medical Center Department of Orthopedics Surgery West China Hospital Sichuan University Chengdu P. R. China

National Engineering Research Center for Biomaterials Sichuan University Chengdu P. R. China

References (42)

Show source-provided references
1. 10.1038/s41579‐018‐0147‐410.1038/s41579‐018‐0147‐4 ↗
2. 10.1038/s44259‐024‐00046‐310.1038/s44259‐024‐00046‐3 ↗
3. 10.1186/s40001‐023‐01121‐710.1186/s40001‐023‐01121‐7 ↗
4. 10.1111/j.1524‐475x.2012.00808.x10.1111/j.1524‐475x.2012.00808.x ↗
5. 10.1038/s41392‐024‐01933‐x10.1038/s41392‐024‐01933‐x ↗
6. 10.1016/j.devcel.2018.01.01910.1016/j.devcel.2018.01.019 ↗
7. 10.1126/sciadv.abj210110.1126/sciadv.abj2101 ↗
8. 10.1016/j.celrep.2021.10946210.1016/j.celrep.2021.109462 ↗
9. 10.1146/annurev‐immunol‐020711‐07494210.1146/annurev‐immunol‐020711‐074942 ↗
10. 10.1021/acsnano.4c1894810.1021/acsnano.4c18948 ↗
11. 10.1038/s41392‐021‐00631‐210.1038/s41392‐021‐00631‐2 ↗
12. 10.3390/ma1704093610.3390/ma17040936 ↗
13. 10.1002/adhm.20150049110.1002/adhm.201500491 ↗
14. 10.1016/j.bioactmat.2022.01.03210.1016/j.bioactmat.2022.01.032 ↗
15. 10.1016/j.jconrel.2024.03.03010.1016/j.jconrel.2024.03.030 ↗
16. 10.3389/fmicb.2023.108300710.3389/fmicb.2023.1083007 ↗
17. 10.1016/j.cej.2024.14908810.1016/j.cej.2024.149088 ↗
18. 10.1146/annurev‐biochem‐032620‐10440110.1146/annurev‐biochem‐032620‐104401 ↗
19. 10.1016/j.coviro.2021.09.01710.1016/j.coviro.2021.09.017 ↗
20. 10.1038/s41590‐021‐01083‐010.1038/s41590‐021‐01083‐0 ↗
21. 10.1126/sciimmunol.abi973310.1126/sciimmunol.abi9733 ↗
22. 10.1089/dia.2010.003910.1089/dia.2010.0039 ↗
23. 10.1038/s41580‐024‐00716‐010.1038/s41580‐024‐00716‐0 ↗
24. 10.1016/j.stem.2022.07.00610.1016/j.stem.2022.07.006 ↗
25. 10.1021/acsnano.1c0420610.1021/acsnano.1c04206 ↗
26. 10.1021/acsnano.1c0449910.1021/acsnano.1c04499 ↗
27. 10.1021/acsnano.1c1104010.1021/acsnano.1c11040 ↗
28. 10.1126/scitranslmed.abn375810.1126/scitranslmed.abn3758 ↗
29. 10.1021/acsnano.1c0603610.1021/acsnano.1c06036 ↗
30. 10.1126/scitranslmed.adf754710.1126/scitranslmed.adf7547 ↗
31. 10.1002/adma.20230463810.1002/adma.202304638 ↗
32. 10.1016/j.colsurfb.2019.11064710.1016/j.colsurfb.2019.110647 ↗
33. 10.1016/j.lfs.2020.11824610.1016/j.lfs.2020.118246 ↗
34. 10.1155/2023/242230310.1155/2023/2422303 ↗
35. 10.1016/j.cej.2024.15072910.1016/j.cej.2024.150729 ↗
36. 10.1016/j.carbon.2022.12.00810.1016/j.carbon.2022.12.008 ↗
37. 10.1016/j.actbio.2023.12.04510.1016/j.actbio.2023.12.045 ↗
38. 10.1016/j.apcatb.2024.12370610.1016/j.apcatb.2024.123706 ↗
39. 10.1002/smll.20230966410.1002/smll.202309664 ↗
40. 10.1002/adfm.20221409110.1002/adfm.202214091 ↗
41. 10.1016/j.jconrel.2024.03.05410.1016/j.jconrel.2024.03.054 ↗
42. 10.1002/advs.20210412810.1002/advs.202104128 ↗